title: Deferasirox for cardiac siderosis in β-thalassaemia major: a multicentre, open label, prospective study.
authors: Department of Clinical and Biological Sciences, University of Turin, Turin, Italy. antonio.piga@unito.it.
authors: Antonio
authors: A
authors: Piga
authors: Filomena
authors: F
authors: Longo
authors: Raffaella
authors: R
authors: Origa
authors: Simona
authors: S
authors: Roggero
authors: Francesca
authors: F
authors: Pinna
authors: Antonietta
authors: A
authors: Zappu
authors: Chiara
authors: C
authors: Castiglioni
authors: Maria Domenica
authors: MD
authors: Cappellini
mesh_terms: D000328:Adult; D001565:Benzoates / Q000008:administration & dosage / Q000627:therapeutic use*; D009202:Cardiomyopathies / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D015913:Chelation Therapy; D000077588:Deferasirox; D005260:Female; D005293:Ferritins / Q000097:blood; D006486:Hemosiderosis / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D006801:Humans; D007502:Iron Chelating Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008099:Liver / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008297:Male; D055118:Medication Adherence; D011446:Prospective Studies; D013318:Stroke Volume; D065227:Transfusion Reaction; D014230:Triazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D055815:Young Adult; D017086:beta-Thalassemia / Q000150:complications* / Q000628:therapy
chemical_list: D001565:Benzoates; D007502:Iron Chelating Agents; D014230:Triazoles; D005293:Ferritins; D000077588:Deferasirox
keywords: heart; iron chelation; iron overload; magnetic resonance imaging